CRISPR Gene Editing Market

Industry Overview

The Global CRISPR (clustered regularly interspaced short palindromic repeats) Gene editing Market is anticipated to grow from USD 1.12 billion in 2023 to USD 16.75 billion by 2030, registering a CAGR of 28.60% during the forecast period 2025-2030. CRISPR gene editing market was a rapidly growing field with significant potential. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary gene editing technology that allows scientists to make precise changes to an organism's DNA.The CRISPR gene editing market encompasses various sectors, including therapeutics, agriculture, and research tools. In the therapeutics sector, CRISPR is being explored as a potential treatment for genetic diseases by editing or repairing faulty genes. Several clinical trials have been conducted or are underway to evaluate the safety and efficacy of CRISPR-based therapies. In agriculture, CRISPR gene editing offers the possibility of creating crops with improved traits such as disease resistance, increased yield, and enhanced nutritional content. The technology could potentially revolutionize the agriculture industry by providing more sustainable and resilient crops. Additionally, the CRISPR gene editing market includes research tools and services. Many companies have developed CRISPR-based tools and kits that enable researchers to perform gene editing experiments more efficiently and accurately. These tools are widely used in academic and industrial laboratories around the world.Since the CRISPR gene editing market is continually evolving, it is advisable to refer to up-to-date sources for the latest developments and market trends.

It is a sophisticated genome-editing technique that allows scientists to easily change DNA sequences and gene function. It has a wide range of possible applications, including genetic defect rectification, disease treatment and prevention, and agricultural growth and resilience augmentation. Despite its promise, though, the technology raises ethical difficulties. The advancement of genome engineering and its prospective applications has had a significant impact on the healthcare and life science industries future. Nevertheless, the business is spending a massive amount of money on R&D activities of CRISPR gene editing products and gene therapies.

Market Segmentation

Insight by Product Type

Based on product type, the global CRISPR gene editing market is bifurcated into CRISPR products and CRISPR services. The CRISPR products are further divided into kits & enzymes, libraries, design tools, antibodies, and others. The kits and enzymes are subdivided into vector-based Cas9 and DNA-free Cas9. The CRISPR services are further divided into gRNA design and vector construction, cell line and engineering, screening services, and others. The kits and enzymes hold a significant share in the market. Because of its high orthogonality, versatility, and efficiency, the clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system was a game-changer in genome editing technology. The CRISPR services are anticipated to have a high ACGR during the forecast period

Insight by Application

Based on application, the global CRISPR gene editing market is segregated into agriculture, biomedical, industrial, and others. The biomedical is further divided into gene therapy, drug discovery, and diagnostics. The biomedical dominates the CRISPR gene editing market owing to the rising number of gene therapy clinical trials, increased adoption of CRISPR editing techniques in various fields of biomedical research, and use of nano-carriers and advancement of new delivery methods will significantly enhance the effectiveness and uniqueness of the technology. 

Insight by End-User

Based on end-user, the global CRISPR gene editing market is classified into academic institutes and research centers, biotechnology companies, contract research organizations (CROs), and pharmaceutical and biopharmaceutical companies. CRISPR technology is being used to boost the productivity of CHO cell lines in a big way. Large molecule therapeutics are frequently produced using these cell lines. As a result of the CRISPR tool's deployment, the biopharmaceutical market is seeing developments, which is fueling the market for the CRISPR gene editing market.

Global CRISPR Gene Editing Market Report Coverage

Industry Dynamics

Industry Trends

The increased funding from the private and government sectors along with a surge in technological development are the trends prevalent in the CRISPR gene editing market.

Growth Drivers

Factors attributing to the growth of the CRISPR gene editing market include rising demand from the food industry to offer superior products having enhanced quality and enrichment in nutrients and rising demand from the pharmaceutical industry to offer treatment of various diseases. Also, to enhance specificity and cost-effectiveness, as well as reduce turnaround time and human errors, research organizations, pharmaceutical and biotechnology firms, and institutes are striving for more efficient genome editing technologies.  Moreover, the growing geriatric population, as well as the increasing number of cancer cases and genetic abnormalities around the world, are predicted to drive up demand for CRISPR gene editing. In recent times, the number of clinical trials for numerous genetic and chronic disorders has increased. This will contribute to the future expansion of the CRISPR gene editing business.

Challenges

The off-target effects and delivery are expected to stymie the expansion of the clustered regularly interspaced short palindromic repeats (CRISPR) gene-editing market during the forecast period. Also, ethical concerns, pending patent issues & results of clinical trials, lack of healthcare budgeting in emerging economies, misuse of CRISPR technology, and consequences related to human genome editing will pose a challenge to the growth of the CRISPR gene editing market.

Opportunities

The development of the worldwide CRISPR gene editing market has been pushed in recent years by the emergence of new cell and gene therapy production centers, partnerships among biotechnology firms, and significant investments, thus creating opportunities for the market. Furthermore, the advancement of genome editing technologies has allowed researchers to investigate a wide range of applications in domains such as industrial, biotechnology, and agricultural research. These sophisticated approaches are simple, super-efficient, and cost-effective, and they allow for multiplexing and high throughput.

Geographic Overview

North America contributes the largest share in the CRISPR gene editing market owing to significant investment by pharmaceutical and biotechnology companies. Also, the increased investment in healthcare infrastructure, rising per capita income, availability of new and developed research laboratories and institutions, and accessibility of approved therapies will accelerate the growth in the region.

Competitive Insight

The significant increase in the adoption of precision medicine globally will lead to investment by industry players to develop novel CRISPR gene editing. Furthermore, the increasing strategic alliances, partnerships, and collaboration will lead to a strong foothold by the industry players in the market.

Merck's expertise in genome editing has resulted in the industry's most comprehensive portfolio of CRISPR and other advanced genomics technologies, which has an impact on every step of the process, from basic research to therapeutic delivery. Gene knockout, targeted integration and mutagenesis, and genetic screening libraries are among the technologies and services offered by the company to help research immune therapeutics, cancer, and infectious illness, among other sectors. Merck's experts are working on new technologies that will increase these uses and speed up health-related research.

CRISPR Therapeutics is a leading gene-editing firm that uses its unique CRISPR/Cas9 gene-editing platform to generate transformational gene-based treatments for critical diseases. CRISPR/Cas9 is a breakthrough technique for making precise, targeted alterations to genomic DNA. The Company's multidisciplinary team of world-class researchers and drug developers is working to turn this technology into revolutionary human therapeutics for a variety of critical disorders. CRISPR Therapeutics has also formed strategic partnerships with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics for diseases where there is a high unmet need.

In October 2021, Merck, a prominent scientific and technology corporation, announced that Cellecta, Inc., a functional genomics products and services provider based in Mountain View, California, has inked an agreement licensing its proprietary CRISPR-Cas9 technology. Merck is paving the way for researchers and scientists to uncover and accelerate next-generation treatments for inherited blood disorders, cancers, and ophthalmological diseases, among others by licensing its revolutionary technologies.

In December 2021, Invitrogen TrueCut HiFi Cas9 Protein, a novel protein from Thermo Fisher Scientific, has been added to Thermo Fisher Scientific's increasing CRISPR gene editing solutions portfolio. CRISPR technology, also known as in vivo gene editing, has grown in popularity as a technique for modifying human DNA. In various cell types, including T cells and induced pluripotent stem cells, the Invitrogen TrueCut HiFi Cas9 Protein minimizes off-target effects as compared to wild-type Cas9 (iPSCs).

Some of the major players in the global CRISPR gene editing market include Merck KGaA, Thermo Fisher Scientific Inc., Applied StemCell, Abcam plc, CRISPR Therapeutics, Cellecta, Inc., GenScript, ToolGen, Inc., Takara Bio Inc., and OriGene Technologies, Inc.

The CRISPR Gene Editing Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2023–2030.

Segments Covered in the Report

• By Product Type 
  • CRISPR Products 
    • Kits & Enzymes
    • Libraries
    • Design Tools
    • Antibodies
    • Others
  • CRISPR Services
    • gRNA Design and Vector Construction
    • Cell Line and Engineering
    • Screening Services
    • Others
• By Application 
  • Agriculture
  • Biomedical
  • Industrial
  • Others
• By End User
  • Academic Institutes and Research Centers
  • Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Pharmaceutical and Biopharmaceutical Companies

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

To explore more about this report - Request a free sample copy

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Product Type
                1.2.2.    By Application 
                1.2.3.    By End User             
                1.2.4.    By Region
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                1.5.1.    Data Sources
                        1.5.1.1. Primary Research
                        1.5.1.2. Secondary Research
                1.5.2.    Methodology
                        1.5.2.1. Data Exploration
                        1.5.2.2. Forecast Parameters
                        1.5.2.3. Data Validation
                        1.5.2.4. Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis
                3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2030

5.    Market Segmentation Estimate and Forecast

        5.1.    By Product Type
                5.1.1.    CRISPR Products
                        5.1.1.1. Market Definition
                        5.1.1.2. Market Estimation and Forecast to 2030  
                5.1.2.    CRISPR Services
                        5.1.2.1. Market Definition
                        5.1.2.2. Market Estimation and Forecast to 2030      
        5.2.    By Application 
                5.2.1.    Agriculture
                        5.2.1.1. Market Definition
                        5.2.1.2. Market Estimation and Forecast to 2030
                5.2.2.    Biomedical
                        5.2.2.1. Market Definition
                        5.2.2.2. Market Estimation and Forecast to 2030
                5.2.3.    Industrial
                        5.2.3.1. Market Definition
                        5.2.3.2. Market Estimation and Forecast to 2030
                5.2.4.    others
                        5.2.4.1. Market Definition
                        5.2.4.2. Market Estimation and Forecast to 2030     
        5.3.    By End User   
                5.3.1.    Academic Institutes and Research Centers
                        5.3.1.1. Market Definition
                        5.3.1.2. Market Estimation and Forecast to 2030
                5.3.2.    Biotechnology Companies
                        5.3.2.1. Market Definition
                        5.3.2.2. Market Estimation and Forecast to 2030
                5.3.3.    Contract Research Organizations (CROs)
                        5.3.3.1. Market Definition
                        5.3.3.2. Market Estimation and Forecast to 2030
                5.3.4.    Pharmaceutical and Biopharmaceutical Companies
                        5.3.4.1. Market Definition
                        5.3.4.2. Market Estimation and Forecast to 2030             
        
6.    North America Market Estimate and Forecast

        6.1.    By Product Type
        6.2.    By Application 
        6.3.    By End User      
        6.4.    By Country – U.S., Canada, and Mexico
                6.4.1.    U.S. Market Estimate and Forecast
                6.4.2.    Canada Market Estimate and Forecast
                6.4.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Product Type
        7.2.    By Application 
        7.3.    By End User        
        7.4.    By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe
                7.4.1.    Germany Market Estimate and Forecast
                7.4.2.    France Market Estimate and Forecast
                7.4.3.    U.K. Market Estimate and Forecast
                7.4.4.    Italy Market Estimate and Forecast
                7.4.5.    Spain Market Estimate and Forecast
                7.4.6.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Product Type
        8.2.    By Application 
        8.3.    By End User       
        8.4.    By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
                8.4.1.    China Market Estimate and Forecast
                8.4.2.    Japan Market Estimate and Forecast
                8.4.3.    India Market Estimate and Forecast
                8.4.4.    South Korea Market Estimate and Forecast
                8.4.5.    Singapore Market Estimate and Forecast
                8.4.6.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Product Type
        9.2.    By Application 
        9.3.    By End User       
        9.4.    By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries
                9.4.1.    Brazil Market Estimate and Forecast
                9.4.2.    Saudi Arabia Market Estimate and Forecast
                9.4.3.    South Africa Market Estimate and Forecast
                9.4.4.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    Merck KGaA
                10.1.1.    Snapshot
                10.1.2.    Overview
                10.1.3.    Offerings
                10.1.4.    Financial Insight
                10.1.5.    Recent Developments
        10.2.    Thermo Fisher Scientific Inc.
                10.2.1.    Snapshot
                10.2.2.    Overview
                10.2.3.    Offerings
                10.2.4.    Financial Insight
                10.2.5.    Recent Developments
        10.3.    Applied StemCell
                10.3.1.    Snapshot
                10.3.2.    Overview
                10.3.3.    Offerings
                10.3.4.    Financial Insight
                10.3.5.    Recent Developments
        10.4.    Abcam plc
                10.4.1.    Snapshot
                10.4.2.    Overview
                10.4.3.    Offerings
                10.4.4.    Financial Insight
                10.4.5.    Recent Developments
        10.5.    CRISPR Therapeutics
                10.5.1.    Snapshot
                10.5.2.    Overview
                10.5.3.    Offerings
                10.5.4.    Financial Insight
                10.5.5.    Recent Developments
        10.6.    Cellecta, Inc.
                10.6.1.    Snapshot
                10.6.2.    Overview
                10.6.3.    Offerings
                10.6.4.    Financial Insight
                10.6.5.    Recent Developments
        10.7.    GenScript
                10.7.1.    Snapshot
                10.7.2.    Overview
                10.7.3.    Offerings
                10.7.4.    Financial Insight
                10.7.5.    Recent Developments
        10.8.    ToolGen, Inc.
                10.8.1.    Snapshot
                10.8.2.    Overview
                10.8.3.    Offerings
                10.8.4.    Financial Insight
                10.8.5.    Recent Developments
        10.9.    Takara Bio Inc.
                10.9.1.    Snapshot
                10.9.2.    Overview
                10.9.3.    Offerings
                10.9.4.    Financial Insight
                10.9.5.    Recent Developments
        10.10.   OriGene Technologies, Inc.
                10.10.1.   Snapshot
                10.10.2.   Overview
                10.10.3.   Offerings
                10.10.4.   Financial Insight
                10.10.5.   Recent Developments        

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1 Sources
Table 2 Study Periods
Table 3 Data Reporting Unit

Table 4 Global CRISPR Gene Editing Market, By Product Type, 2018 - 2023 (USD Billion)
Table 5 Global CRISPR Gene Editing Market, By Product Type, 2025–2030 (USD Billion)
Table 6 Global CRISPR Gene Editing Market, By Application, 2018 - 2023 (USD Billion)
Table 7 Global CRISPR Gene Editing Market, By Application, 2025–2030 (USD Billion)
Table 8 Global CRISPR Gene Editing Market, By End-User, 2018 - 2023 (USD Billion)
Table 9 Global CRISPR Gene Editing Market, By End-User, 2025–2030 (USD Billion)
Table 10 Global CRISPR Gene Editing Market, By Region, 2018 - 2023 (USD Billion)
Table 11 Global CRISPR Gene Editing Market, By Region, 2025–2030 (USD Billion)
Table 12 North America CRISPR Gene Editing Market, By Product Type, 2018 - 2023 (USD Billion)
Table 13 North America CRISPR Gene Editing Market, By Product Type, 2025–2030 (USD Billion)
Table 14 North America CRISPR Gene Editing Market, By Application, 2018 - 2023 (USD Billion)
Table 15 North America CRISPR Gene Editing Market, By Application, 2025–2030 (USD Billion)
Table 16 North America CRISPR Gene Editing Market, By End-User, 2018 - 2023 (USD Billion)
Table 17 North America CRISPR Gene Editing Market, By End-User, 2025–2030 (USD Billion)
Table 18 North America CRISPR Gene Editing Market, By Region, 2018 - 2023 (USD Billion)
Table 19 North America CRISPR Gene Editing Market, By Region, 2025–2030 (USD Billion)
Table 20 Europe CRISPR Gene Editing Market, By Product Type, 2018 - 2023 (USD Billion)
Table 21 Europe CRISPR Gene Editing Market, By Product Type, 2025–2030 (USD Billion)
Table 22 Europe CRISPR Gene Editing Market, By Application, 2018 - 2023 (USD Billion)
Table 23 Europe CRISPR Gene Editing Market, By Application, 2025–2030 (USD Billion)
Table 24 Europe CRISPR Gene Editing Market, By End-User, 2018 - 2023 (USD Billion)
Table 25 Europe CRISPR Gene Editing Market, By End-User, 2025–2030 (USD Billion)
Table 26 Europe CRISPR Gene Editing Market, By Region, 2018 - 2023 (USD Billion)
Table 27 Europe CRISPR Gene Editing Market, By Region, 2025–2030 (USD Billion)
Table 28 Asia-Pacific CRISPR Gene Editing Market, By Product Type, 2018 - 2023 (USD Billion)
Table 29 Asia-Pacific CRISPR Gene Editing Market, By Product Type, 2025–2030 (USD Billion)
Table 30 Asia-Pacific CRISPR Gene Editing Market, By Application, 2018 - 2023 (USD Billion)
Table 31 Asia-Pacific CRISPR Gene Editing Market, By Application, 2025–2030 (USD Billion)
Table 32 Asia-Pacific CRISPR Gene Editing Market, By End-User, 2018 - 2023 (USD Billion)
Table 33 Asia-Pacific CRISPR Gene Editing Market, By End-User, 2025–2030 (USD Billion)
Table 34 Asia-Pacific CRISPR Gene Editing Market, By Region, 2018 - 2023 (USD Billion)
Table 35 Asia-Pacific CRISPR Gene Editing Market, By Region, 2025–2030 (USD Billion)
Table 36  RoW CRISPR Gene Editing Market, By Product Type, 2018 - 2023 (USD Billion)
Table 37  RoW CRISPR Gene Editing Market, By Product Type, 2025–2030 (USD Billion)
Table 38  RoW CRISPR Gene Editing Market, By Application, 2018 - 2023 (USD Billion)
Table 39  RoW CRISPR Gene Editing Market, By Application, 2025–2030 (USD Billion)
Table 40  RoW CRISPR Gene Editing Market, By End-User, 2018 - 2023 (USD Billion)
Table 41  RoW CRISPR Gene Editing Market, By End-User, 2025–2030 (USD Billion)
Table 42  RoW CRISPR Gene Editing Market, By Region, 2018 - 2023 (USD Billion)
Table 43  RoW CRISPR Gene Editing Market, By Region, 2025–2030 (USD Billion)
Table 44 Snapshot – Merck KGaA
Table 45 Snapshot – Thermo Fisher Scientific Inc.
Table 46 Snapshot – Applied StemCell
Table 47 Snapshot – Abcam plc
Table 48 Snapshot – CRISPR Therapeutics
Table 49 Snapshot – Cellecta, Inc.
Table 50 Snapshot – GenScript
Table 51 Snapshot – ToolGen, Inc.
Table 52 Snapshot – Takara Bio Inc.
Table 53 Snapshot – OriGene Technologies, Inc.

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Sources for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global CRISPR Gene Editing Market- Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global CRISPR Gene Editing Market Highlight
Figure 12 Global CRISPR Gene Editing Market, By Product Type, 2018 - 2030 (USD Billion)
Figure 13 Global CRISPR Gene Editing Market, By Application, 2018 - 2030 (USD Billion)
Figure 14 Global CRISPR Gene Editing Market, By End-User, 2018 - 2030 (USD Billion)
Figure 15 Global CRISPR Gene Editing Market, By Region, 2018 - 2030 (USD Billion)
Figure 16 North America CRISPR Gene Editing Market Highlight
Figure 17 North America CRISPR Gene Editing Market, By Product Type, 2018 - 2030 (USD Billion)
Figure 18 North America CRISPR Gene Editing Market, By Application, 2018 - 2030 (USD Billion)
Figure 19 North America CRISPR Gene Editing Market, By End-User, 2018 - 2030 (USD Billion)
Figure 2 North America CRISPR Gene Editing Market, By Region, 2018 - 2030 (USD Billion)
Figure 21 Europe CRISPR Gene Editing Market Highlight
Figure 22 Europe CRISPR Gene Editing Market, By Product Type, 2018 - 2030 (USD Billion)
Figure 23 Europe CRISPR Gene Editing Market, By Application, 2018 - 2030 (USD Billion)
Figure 24 Europe CRISPR Gene Editing Market, By End-User, 2018 - 2030 (USD Billion)
Figure 25 Europe CRISPR Gene Editing Market, By Region, 2018 - 2030 (USD Billion)
Figure 26 Asia-Pacific CRISPR Gene Editing Market Highlight
Figure 27 Asia-Pacific CRISPR Gene Editing Market, By Product Type, 2018 - 2030 (USD Billion)
Figure 28 Asia-Pacific CRISPR Gene Editing Market, By Application, 2018 - 2030 (USD Billion)
Figure 29 Asia-Pacific CRISPR Gene Editing Market, By End-User, 2018 - 2030 (USD Billion)
Figure 30 Asia-Pacific CRISPR Gene Editing Market, By Region, 2018 - 2030 (USD Billion)
Figure 31 RoW CRISPR Gene Editing Market Highlight
Figure 32 RoW CRISPR Gene Editing Market, By Product Type, 2018 - 2030 (USD Billion)
Figure 33 RoW CRISPR Gene Editing Market, By Application, 2018 - 2030 (USD Billion)
Figure 34 RoW CRISPR Gene Editing Market, By End-User, 2018 - 2030 (USD Billion)
Figure 35 RoW CRISPR Gene Editing Market, By Region, 2018 - 2030 (USD Billion)